CA22559-2 - 0x0000000000003092

Study Number: CA22559
Group Number: 2
Study Requirement: Cystic Fibrosis
Stipend: up to £ 1,487

Study Criteria:

  • Age: 18 - 0
  • BMI: 16 - 0
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed as a treatment for Cystic Fibrosis.
  • Route of Administration: Oral
  • Blood Draws: 17

Study Schedule:

  • Schedule Type: Return Only
  • Study Length: 7 Returns & 3 Phone Calls

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Sunday Jul 30 2017 7:00PM Sunday Jul 30 2017 8:00PM 1 Belfast
Return Monday Jul 31 2017 6:30AM Monday Jul 31 2017 9:30PM 1 Belfast
Return Tuesday Aug 1 2017 8:00AM Tuesday Aug 1 2017 9:30AM 1 Belfast
Phone participant* Saturday Aug 5 2017 1:00PM 1 Belfast
Return Sunday Aug 6 2017 7:45AM Sunday Aug 6 2017 11:30AM 1 Belfast
Phone participant* Saturday Aug 12 2017 1:00PM 1 Belfast
Return Sunday Aug 13 2017 7:30AM Sunday Aug 13 2017 9:30PM 1 Belfast
Return Monday Aug 14 2017 7:30AM Monday Aug 14 2017 9:30AM 1 Belfast
Phone participant* Saturday Aug 19 2017 1:00PM 1 Belfast
Return Sunday Aug 20 2017 8:00AM Sunday Aug 20 2017 10:45AM 1 Belfast